T. Rowe Price Associates
SGEN

T. Rowe Price Associates’s Seagen Inc. Common Stock SGEN Stock Holding History

T. Rowe Price Associates’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-612,737
Closed -$130M – 2943
2023
Q3 		$130M Sell
612,737
-11,566
-2% -$2.31M 0.02% 466
2023
Q2 		$120M Sell
624,303
-956,513
-61% -$190M 0.02% 495
2023
Q1 		$320M Buy
1,580,816
+685,883
+77% +$110M 0.05% 303
2022
Q4 		$115M Buy
894,933
+89,624
+11% +$11.6M 0.02% 466
2022
Q3 		$110M Sell
805,309
-1,709,580
-68% -$279M 0.02% 469
2022
Q2 		$445M Sell
2,514,889
-2,336,066
-48% -$337M 0.06% 314
2022
Q1 		$699M Sell
4,850,955
-1,784,291
-27% -$241M 0.07% 270
2021
Q4 		$1.03B Sell
6,635,246
-354,618
-5% -$59.4M 0.09% 218
2021
Q3 		$1.19B Buy
6,989,864
+199,759
+3% +$31.1M 0.11% 191
2021
Q2 		$1.07B Sell
6,790,105
-324,065
-5% -$48.2M 0.1% 213
2021
Q1 		$988M Sell
7,114,170
-412,070
-5% -$66.4M 0.1% 223
2020
Q4 		$1.32B Sell
7,526,240
-1,411,722
-16% -$263M 0.14% 164
2020
Q3 		$1.75B Sell
8,937,962
-276,166
-3% -$46.2M 0.2% 103
2020
Q2 		$1.57B Sell
9,214,128
-120,843
-1% -$18M 0.2% 104
2020
Q1 		$1.08B Sell
9,334,971
-493,059
-5% -$54.6M 0.17% 129
2019
Q4 		$1.12B Buy
9,828,030
+760,357
+8% +$80.6M 0.15% 148
2019
Q3 		$774M Buy
9,067,673
+864,171
+11% +$63.4M 0.11% 206
2019
Q2 		$568M Buy
8,203,502
+108,801
+1% +$7.62M 0.08% 264
2019
Q1 		$593M Buy
8,094,701
+19,961
+0.2% +$1.42M 0.09% 228
2018
Q4 		$458M Sell
8,074,740
-2,069,011
-20% -$130M 0.08% 249
2018
Q3 		$782M Sell
10,143,751
-427,348
-4% -$31.5M 0.11% 195
2018
Q2 		$702M Buy
10,571,099
+839,108
+9% +$48.1M 0.11% 194
2018
Q1 		$509M Buy
9,731,991
+1,933,345
+25% +$105M 0.08% 250
2017
Q4 		$417M Buy
7,798,646
+4,256,018
+120% +$249M 0.07% 298
2017
Q3 		$193M Sell
3,542,628
-302,890
-8% -$15.5M 0.03% 454
2017
Q2 		$199M Buy
3,845,518
+78,790
+2% +$5.01M 0.04% 440
2017
Q1 		$237M Buy
3,766,728
+202,722
+6% +$12.7M 0.04% 393
2016
Q4 		$188M Sell
3,564,006
-1,188,987
-25% -$71.5M 0.04% 436
2016
Q3 		$257M Buy
4,752,993
+1,063,004
+29% +$50.4M 0.05% 355
2016
Q2 		$149M Sell
3,689,989
-5,964
-0.2% -$227K 0.03% 472
2016
Q1 		$130M Buy
3,695,953
+190,483
+5% +$6.4M 0.03% 484
2015
Q4 		$157M Sell
3,505,470
-406
-0% -$16.9K 0.03% 450
2015
Q3 		$135M Buy
3,505,876
+785,620
+29% +$35.4M 0.03% 496
2015
Q2 		$132M Buy
2,720,256
+30,684
+1% +$1.27M 0.03% 532
2015
Q1 		$95.1M Buy
2,689,572
+1,202,218
+81% +$41M 0.02% 633
2014
Q4 		$47.8M Sell
1,487,354
-850,270
-36% -$29.6M 0.01% 853
2014
Q3 		$86.9M Sell
2,337,624
-195,165
-8% -$7.67M 0.02% 645
2014
Q2 		$96.9M Sell
2,532,789
-308,414
-11% -$11.7M 0.02% 643
2014
Q1 		$129M Buy
2,841,203
+377,260
+15% +$18M 0.03% 558
2013
Q4 		$98.3M Buy
2,463,943
+104,343
+4% +$4.26M 0.02% 623
2013
Q3 		$103M Sell
2,359,600
-57,200
-2% -$2.38M 0.03% 582
2013
Q2 		$76M Buy
+2,416,800
New +$84.3M 0.02% 651

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

T. Rowe Price Associates's SGEN Position: Q4 2023 in Review

T. Rowe Price Associates sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 612,737 shares — an estimated $130M sold.

T. Rowe Price Associates first reported a position in SGEN in Q2 2013 and held it in 42 quarters. The position peaked at $1.75B in Q3 2020. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • T. Rowe Price Associates reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 612,737 Seagen Inc. Common Stock shares in Q4 2023, an estimated $130M.
  • T. Rowe Price Associates first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • T. Rowe Price Associates's Seagen Inc. Common Stock position peaked at $1.75B in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.